Anika Therapeutics, Inc. (ANIK)
21.31
-0.47
(-2.16%)
USD |
NASDAQ |
Aug 24, 16:00
21.31
0.00 (0.00%)
After-Hours: 19:20
Anika Therapeutics Price to Book Value : 2.077 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 2.123 |
| August 20, 2026 | 2.080 |
| August 19, 2026 | 2.072 |
| August 18, 2026 | 2.103 |
| August 17, 2026 | 2.093 |
| August 14, 2026 | 2.096 |
| August 13, 2026 | 2.064 |
| August 12, 2026 | 2.148 |
| August 11, 2026 | 2.070 |
| August 10, 2026 | 2.016 |
| August 07, 2026 | 2.088 |
| August 06, 2026 | 1.965 |
| August 05, 2026 | 1.871 |
| August 04, 2026 | 1.912 |
| August 03, 2026 | 2.021 |
| July 31, 2026 | 1.880 |
| July 30, 2026 | 1.762 |
| July 29, 2026 | 1.576 |
| July 28, 2026 | 1.477 |
| July 27, 2026 | 1.464 |
| July 24, 2026 | 1.457 |
| July 23, 2026 | 1.430 |
| July 22, 2026 | 1.463 |
| July 21, 2026 | 1.478 |
| July 20, 2026 | 1.468 |
| Date | Value |
|---|---|
| July 17, 2026 | 1.487 |
| July 16, 2026 | 1.542 |
| July 15, 2026 | 1.553 |
| July 14, 2026 | 1.513 |
| July 13, 2026 | 1.537 |
| July 10, 2026 | 1.521 |
| July 09, 2026 | 1.568 |
| July 08, 2026 | 1.593 |
| July 07, 2026 | 1.547 |
| July 06, 2026 | 1.563 |
| July 02, 2026 | 1.497 |
| July 01, 2026 | 1.480 |
| June 30, 2026 | 1.426 |
| June 29, 2026 | 1.497 |
| June 26, 2026 | 1.506 |
| June 25, 2026 | 1.458 |
| June 24, 2026 | 1.469 |
| June 23, 2026 | 1.455 |
| June 22, 2026 | 1.416 |
| June 18, 2026 | 1.438 |
| June 17, 2026 | 1.420 |
| June 16, 2026 | 1.426 |
| June 15, 2026 | 1.457 |
| June 12, 2026 | 1.468 |
| June 11, 2026 | 1.468 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Perspective Therapeutics, Inc. | 1.120 |
| MiMedx Group, Inc. | 2.887 |
| ABVC BioPharma, Inc. | 2.115 |
| Enovis Corp. | 0.9846 |
| Edwards Lifesciences Corp. | 4.915 |
Price to Book Value Related Metrics
| PS Ratio | 2.488 |
| Price to Free Cash Flow | 534.04 |
| Price | 21.31 |
| Earnings Yield | -1.29% |
| Market Cap | 285.19M |